Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising interim safety and efficacy data reported for Gd-Tex

Nov. 3, 1997

First oral, tumor-activated anticancer drug filed by Roche

Oct. 31, 1997

Temozolomide: phase II efficacy and tolerability data in patients with high-grade glioma

Oct. 31, 1997

Takeda discovers new Taxol-like compound

Oct. 31, 1997

HMR discloses azasteroids for estrogen/androgen-mediated disorders

Oct. 31, 1997

IntraBiotics codevelops IB-367 with Pharmacia & Upjohn

Oct. 31, 1997

Angiogenesis-inhibitory peptides available for licensing from NIH

Oct. 31, 1997

BE-52440A and BE-52440B: novel antitumor antibiotics reported in patent literature

Oct. 31, 1997

Inflammatory and angiogenic protein-related technology available for licensing

Oct. 30, 1997

Neovascularization inhibitors disclosed by Takeda

Oct. 30, 1997

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...